跳至主要内容
临床试验/NCT07494838
NCT07494838尚未招募不适用

IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success

Lucas R. Cusumano, MD1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2026年12月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
25
试验地点
1
主要终点
Compare metabolic activity

研究概览

简要总结

Several clinical trials on genicular artery embolization (GAE) show significant clinical benefit for the majority of patients. However, a proportion of patients do not benefit from GAE, and responses vary across individual patients. Changes in metabolic activity on non-invasive imaging may correlate with improvement in symptoms of knee osteoarthritis. This study will assess changes in metabolic uptake on a hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) system in subjects undergoing GAE.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provided informed consent
  • Age ≥ 40 years
  • Ineligibility for or refusal of surgical management
  • Moderate-severe knee pain as determined by visual analog scale > 5 out of 10
  • Osteoarthritis based on X-ray. Kellgren-Lawrence score > 2 based on radiograph completed within 3 months of procedure date
  • Resistant/failed some form of conservative treatment (e.g. NSAIDS/physical therapy/steroid joint injection/hyaluronic acid joint injection) for at least 3 months
  • Able to comply with all treatments and protocol follow-up visits

排除标准

  • Mild knee pain as determined by visual analog scale < 5 out of 10
  • OA on knee radiograph resulting in greater than 20 degree varus or valgus angulation
  • Moderate loss of kidney function, define as estimated glomerular filtration rate of less than 45 mL/min.
  • Significant arterial atherosclerosis that would limit selective angiography
  • History of fibromyalgia, autoimmune, or inflammatory disorder
  • History of any lumbar spine surgery, spine injections, or radicular pain in the extremity believed to originate from the spine
  • Allergy to iodinated contrast agents
  • Active infection or malignancy
  • Recent (within 12 months) or active cigarette use
  • Prior total or partial knee replacement in the subject knee
  • Active pregnancy
  • Uncorrectable bleeding diathesis
  • Presence of pacemakers, aneurysm clips, neurostimulators, or any other metal implant not compatible with PET/MRI

结局指标

主要结局

Compare metabolic activity

时间窗: Screening, Month 6

To compare change in metabolic activity detected by PET/MRI as defined as percentage change in maximum standardized uptake value (SUVmax) and incidence of clinical response in patients undergoing GAE as defined as a 50% reduction in Western Ontario and McMaster Universities Arthritis Index (WOMAC).

次要结局

  • Associate changes in metabolic activity detected by PET(Screening, Month 6)
  • Assess osseous metabolic abnormalities correlation with osseous abnormalities and cartilage degeneration(Screening, Month 6)
  • Safety of GAE(Treatment, Month 3, Month 6, Month 12)
  • Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) as a Measure of Treatment Efficacy(Screen, Month 3, Month 6, Month 12)
  • Change From Baseline in Visual Analog Scale (VAS) as a Measure of Treatment Efficacy(Screen, Month 3, Month 6, Month 12)
  • Assess KOOS5(Screen, Month 3, Month 6, Month 12)

研究者

发起方
Lucas R. Cusumano, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Lucas R. Cusumano, MD

Interventional Radiologist, Assistant Clinical Professor

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验